Lidija Covic

Tufts University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

42h-index6.0kcitations150works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protease and Inhibitor Mechanisms(54), Blood Coagulation and Thrombosis Mechanisms(43), Signaling Pathways in Disease(38), Phytochemistry and Bioactive Compounds(19), Cell Adhesion Molecules Research(17)

Publications150 total

Coagulation protease-activated receptor-2 (PAR2) promotes dyslipidemia, obesity and MASLD through repression of the hepatic pioneer factor HNF4α
JHEP Reports·2026Open Access
Suppression of Heart Failure With PAR1 Pepducin Technology in a Pressure Overload Model in Mice
Circulation Heart Failure·2023· 5 citedOpen Access
Data from MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer
2023Open Access
Supplementary Data from MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer
2023Open Access
Supplementary Data from MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer
2023Open Access
Data from MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer
2023Open Access
Supplementary Data from MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer
2023Open Access
Supplementary Data from MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer
2023Open Access
Supplementary Data from MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer
2023Open Access
Supplementary Data from MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast Cancer
2023Open Access
Supplementary Fig. S2 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
2023Open Access
Supplementary Table S1 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
2023Open Access
Supplementary Fig. S3 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
2023Open Access
Data from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
2023Open Access
Supplementary Fig. S3 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
2023Open Access
Supplementary Table S1 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
2023Open Access
Supplementary Table S2 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
2023Open Access
Supplementary Fig. S1 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
2023Open Access
Supplementary Fig. S2 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
2023Open Access
Supplementary Fig. S4 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Athan Kuliopulos(46), Anika Agarwal(11), Nga Nguyen(9), Katie O’Callaghan(8), Nicole C. Kaneider(6), Γεώργιος Κούκος(6), Elizabeth K. Fletcher(6), Andrew J. Leger(5), Karyn M. Austin(5), Andrew Bohm(5), Sarah L. Tressel(5), James Baleja(5), Nga Nguyen(5), Rajashree Rana(5), Suzanne L. Jacques(4), Caitlin Foley(4), Carey Kimmelstiel(4), Andrew Shearer(4), Adrienne Boire(3), George Perides(3)